Two new platforms for storing and analyzing genomic data have raised venture capital recently, with Curoverse announcing $1.5 million in seed funding in mid-December and Tute Genomics announcing $1.5 million in seed funding on Dec. 31. Curoverse is a specialized private-cloud system, while Tute Genomics is a pure cloud service. Both are riding the waves of cheaper gene-sequencing costs, data storage and computing power, assuming it will result in a deluge of demand for genomic analysis over the next few years. They’re not alone: We’ve covered numerous startups trying to do the same thing, including DNAnexus, Bina Technologies, Spiral Genetics and Appistry.

Comments have been disabled for this post